持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/04/25 | 3,085 | 3,105 | 3,065 | 3,105 | -5 | -0.2% | 17,900 |
| 2025/04/24 | 3,135 | 3,135 | 3,090 | 3,110 | -30 | -1% | 15,200 |
| 2025/04/23 | 3,115 | 3,145 | 3,110 | 3,140 | +65 | +2.1% | 25,200 |
| 2025/04/22 | 3,045 | 3,110 | 3,045 | 3,075 | +30 | +1% | 17,600 |
| 2025/04/21 | 3,040 | 3,070 | 3,010 | 3,045 | -20 | -0.7% | 15,000 |
| 2025/04/18 | 2,979 | 3,065 | 2,949 | 3,065 | +123 | +4.2% | 17,200 |
| 2025/04/17 | 2,931 | 2,951 | 2,931 | 2,942 | -21 | -0.7% | 11,800 |
| 2025/04/16 | 2,951 | 2,984 | 2,936 | 2,963 | +10 | +0.3% | 16,700 |
| 2025/04/15 | 2,979 | 2,979 | 2,947 | 2,953 | -2 | -0.1% | 16,600 |
| 2025/04/14 | 2,950 | 2,976 | 2,930 | 2,955 | +21 | +0.7% | 22,900 |
| 2025/04/11 | 2,888 | 2,939 | 2,836 | 2,934 | -96 | -3.2% | 35,300 |
| 2025/04/10 | 3,110 | 3,110 | 2,985 | 3,030 | +142 | +4.9% | 31,600 |
| 2025/04/09 | 2,891 | 2,930 | 2,870 | 2,888 | -92 | -3.1% | 43,200 |
| 2025/04/08 | 2,953 | 2,997 | 2,920 | 2,980 | +77 | +2.7% | 36,500 |
| 2025/04/07 | 2,895 | 2,999 | 2,849 | 2,903 | -112 | -3.7% | 48,100 |
| 2025/04/04 | 3,040 | 3,065 | 2,987 | 3,015 | -85 | -2.7% | 42,400 |
| 2025/04/03 | 3,100 | 3,120 | 3,045 | 3,100 | -30 | -1% | 34,400 |
| 2025/04/02 | 3,235 | 3,245 | 3,130 | 3,130 | -90 | -2.8% | 24,600 |
| 2025/04/01 | 3,205 | 3,295 | 3,205 | 3,220 | +40 | +1.3% | 25,600 |
| 2025/03/31 | 3,265 | 3,265 | 3,170 | 3,180 | -95 | -2.9% | 32,400 |
| 2025/03/28 | 3,380 | 3,380 | 3,250 | 3,275 | -135 | -4% | 37,400 |
| 2025/03/27 | 3,315 | 3,410 | 3,310 | 3,410 | +60 | +1.8% | 40,200 |
| 2025/03/26 | 3,305 | 3,360 | 3,265 | 3,350 | +50 | +1.5% | 54,600 |
| 2025/03/25 | 3,260 | 3,300 | 3,250 | 3,300 | +60 | +1.9% | 17,900 |
| 2025/03/24 | 3,335 | 3,335 | 3,235 | 3,240 | -75 | -2.3% | 25,600 |
| 2025/03/21 | 3,285 | 3,320 | 3,280 | 3,315 | +30 | +0.9% | 25,900 |
| 2025/03/19 | 3,280 | 3,320 | 3,280 | 3,285 | +5 | +0.2% | 17,800 |
| 2025/03/18 | 3,285 | 3,325 | 3,280 | 3,280 | -5 | -0.2% | 32,400 |
| 2025/03/17 | 3,270 | 3,300 | 3,270 | 3,285 | +15 | +0.5% | 23,100 |
| 2025/03/14 | 3,295 | 3,305 | 3,265 | 3,270 | -40 | -1.2% | 34,900 |
| 2025/03/13 | 3,330 | 3,345 | 3,295 | 3,310 | -25 | -0.7% | 18,600 |
| 2025/03/12 | 3,270 | 3,335 | 3,270 | 3,335 | +35 | +1.1% | 17,700 |
| 2025/03/11 | 3,260 | 3,320 | 3,245 | 3,300 | +30 | +0.9% | 29,700 |
| 2025/03/10 | 3,270 | 3,300 | 3,265 | 3,270 | +25 | +0.8% | 15,200 |
| 2025/03/07 | 3,280 | 3,280 | 3,220 | 3,245 | -65 | -2% | 29,100 |
| 2025/03/06 | 3,320 | 3,335 | 3,270 | 3,310 | +20 | +0.6% | 28,400 |
| 2025/03/05 | 3,250 | 3,305 | 3,240 | 3,290 | +50 | +1.5% | 37,000 |
| 2025/03/04 | 3,205 | 3,255 | 3,200 | 3,240 | +55 | +1.7% | 26,900 |
| 2025/03/03 | 3,130 | 3,185 | 3,130 | 3,185 | +55 | +1.8% | 27,300 |
| 2025/02/28 | 3,155 | 3,160 | 3,115 | 3,130 | -15 | -0.5% | 30,800 |
| 2025/02/27 | 3,150 | 3,150 | 3,120 | 3,145 | +20 | +0.6% | 20,100 |
| 2025/02/26 | 3,165 | 3,170 | 3,110 | 3,125 | -10 | -0.3% | 29,600 |
| 2025/02/25 | 3,050 | 3,160 | 3,035 | 3,135 | +80 | +2.6% | 31,200 |
| 2025/02/21 | 3,090 | 3,090 | 3,040 | 3,055 | -35 | -1.1% | 22,100 |
| 2025/02/20 | 3,150 | 3,150 | 3,090 | 3,090 | -70 | -2.2% | 32,900 |
| 2025/02/19 | 3,230 | 3,235 | 3,155 | 3,160 | -75 | -2.3% | 20,800 |
| 2025/02/18 | 3,225 | 3,260 | 3,195 | 3,235 | +10 | +0.3% | 14,500 |
| 2025/02/17 | 3,265 | 3,275 | 3,225 | 3,225 | -25 | -0.8% | 8,600 |
| 2025/02/14 | 3,260 | 3,265 | 3,220 | 3,250 | +15 | +0.5% | 14,300 |
| 2025/02/13 | 3,185 | 3,265 | 3,175 | 3,235 | +65 | +2.1% | 19,900 |
51～
100
件表示中 / 3738件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 287,900円 | +5.1% | -7.0% | 2.78% | 18.90倍 | 0.78倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| サンバイオ | 222,300円 | - | - | 0.00% | - | 102.96倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ゼリア新薬 | 203,700円 | +3.1% | -6.5% | 2.36% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 148,100円 | -2.4% | -52.3% | 3.85% | 17.73倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 205,500円 | +4.1% | -3.1% | 2.82% | 17.82倍 | 1.55倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
